Star Combo Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Star Combo Pharma has a total shareholder equity of A$33.5M and total debt of A$19.9K, which brings its debt-to-equity ratio to 0.06%. Its total assets and total liabilities are A$41.0M and A$7.4M respectively. Star Combo Pharma's EBIT is A$1.3M making its interest coverage ratio 19.9. It has cash and short-term investments of A$9.2M.
Key information
0.06%
Debt to equity ratio
AU$19.90k
Debt
| Interest coverage ratio | 19.9x |
| Cash | AU$9.19m |
| Equity | AU$33.53m |
| Total liabilities | AU$7.45m |
| Total assets | AU$40.98m |
Recent financial health updates
Recent updates
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon
Mar 20
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?
Nov 21Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think
Mar 02Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt
Dec 24
Financial Position Analysis
Short Term Liabilities: S66's short term assets (A$16.6M) exceed its short term liabilities (A$2.9M).
Long Term Liabilities: S66's short term assets (A$16.6M) exceed its long term liabilities (A$4.5M).
Debt to Equity History and Analysis
Debt Level: S66 has more cash than its total debt.
Reducing Debt: S66's debt to equity ratio has increased from 0% to 0.06% over the past 5 years.
Debt Coverage: S66's debt is well covered by operating cash flow (9846.8%).
Interest Coverage: S66's interest payments on its debt are well covered by EBIT (19.9x coverage).